EXHIBIT AT SEATS X MLCC 2026

Exhibit at SEATS X MLCC 2026

We are reaching out to more than 700 potential participants from academic and research institutions, healthcare organisations, and global companies to give them a preview of what awaits them at SEATS X MLCC 2026. By bringing together the 5th Annual Congress of the South East Asian Thoracic Society (SEATS 2026) and the 6th Multi-Disciplinary Lung Cancer Conference (MLCC 2026), this co-located event offers participating companies a unique opportunity to engage with a broader multidisciplinary audience and expand their business reach.

By becoming a partner of SEATS X MLCC 2026, you will have the opportunity to showcase your company, products, and innovations to leading thoracic surgeons, pulmonologists, oncologists, allied health professionals, researchers, and key decision-makers from across the region, strengthening your brand visibility and corporate profile. The Congress also provides valuable networking opportunities to build meaningful business partnerships, foster scientific collaborations, and explore new market opportunities.

In addition, participants will gain valuable insights into the latest advancements and emerging trends in thoracic surgery, multidisciplinary lung cancer care, and related technologies.

Choosing to sponsor SEATS X MLCC 2026 is an investment in one of the region’s premier multidisciplinary scientific meetings. It offers an exceptional platform to globalise your brand, reinforce confidence in your products and solutions, connect with key stakeholders, and elevate your corporate image. We look forward to welcoming you as a valued partner in making this landmark event a success.

Ready to Exhibit?

Drop an email to ongj@kenes.com or complete the form below, and our team will be in touch with available packages and opportunities.

Time	09:00 – 16:00 (GMT+8)
Venue	Grand Hyatt Singapore, Residence 6, Level 3
Format	Rotating hands-on stations with focused short didactic sessions and practical demonstrations
Introduction	This hands-on workshop is designed to strengthen both the technical execution and clinical reasoning required for advanced bronchoscopy and interventional pulmonology. Each station combines short expert demonstrations with deliberate practice, troubleshooting, and discussion of indications, safety checks, and complication management
Objectives	– Develop a structured approach to procedure planning, including indication, airway anatomy, lesion or nodal target, device selection, and rescue strategy. – Improve hands-on familiarity with convex-probe EBUS bronchoscopes, R-EBUS probes, guide sheaths, biopsy tools, cryoprobes, ablative devices, rigid bronchoscopes, and airway stents. – Practice stepwise technical execution with attention to ergonomics, team communication, equipment readiness, and procedural flow. – Recognise pitfalls early and apply practical strategies for bleeding, airway obstruction, pneumothorax risk, device malposition, and loss of target access.
Target Participants	Respiratory physicians, interventional pulmonologists, thoracic surgeons, respiratory and thoracic fellows and trainees, intensivists with an interest in advanced bronchoscopy, bronchoscopy nurses, and allied healthcare professionals involved in bronchoscopy services.
Participants Number	30 pax
Lead Faculty	Eric D. Tenda Melvin Tay C.K. SS Kho
Faculty	Regional and international multidisciplinary experts in respiratory medicine and interventional pulmonology

Time	07:30 – 17:00 (GMT+8)
Venue	Grand Hyatt Singapore, Residence 5, Level 3
Format	Interactive, case-based multidisciplinary workshop focused on precision lung cancer care, integrating molecular tumour board discussions, real-world case simulations, and live audience polling.
Introduction	This workshop focuses on the practical application of molecular profiling in lung cancer, including NGS, liquid biopsy, and minimal residual disease (MRD). Emphasis is placed on translating biomarker data into real-world clinical decision-making across early-stage and advanced disease settings.
Objectives	– Apply NGS and molecular profiling in lung cancer management – Interpret ctDNA and MRD results in clinical practice – Integrate biomarker data into treatment decisions – Manage early and advanced NSCLC using precision oncology approaches – Conduct multidisciplinary tumour board (MTB)–style decision-making in clinical scenarios – Discuss real-world challenges in implementing molecular diagnostics in routine practice – Evaluate emerging roles of perioperative and adjuvant biomarker-guided therapies
Target Participants	Medical oncologists, thoracic surgeons, pulmonologists, pathologists, radiation oncologists, trainees, and allied health professionals.
Lead Faculty	Aaron Tan
Faculty	Regional and international multidisciplinary experts in thoracic oncology and molecular diagnostics.

American Samoa	Gibraltar	Panama
Andorra	Greece	Poland
Antigua and Barbuda	Greenland	Portugal
Aruba	Guam	Puerto Rico
Australia	Guyana	Qatar
Austria	Hong Kong SAR, China	Romania
Bahamas, The	Hungary	Russian Federation
Bahrain	Iceland	San Marino
Barbados	Ireland	Saudi Arabia
Belgium	Isle of Man	Seychelles
Bermuda	Israel	Singapore
British Virgin Islands	Italy	Sint Maarten (Dutch part)
Brunei Darussalam	Japan	Slovak Republic
Bulgaria	Korea, Rep.	Slovenia
Canada	Kuwait	Spain
Cayman Islands	Latvia	St. Kitts and Nevis
Channel Islands	Liechtenstein	St. Martin (French part)
Chile	Lithuania	Sweden
Costa Rica	Luxembourg	Switzerland
Croatia	Macao SAR, China	Taiwan, China
Curaçao	Malta	Trinidad and Tobago
Cyprus	Monaco	Turks and Caicos Islands
Czechia	Nauru	United Arab Emirates
Denmark	Netherlands	United Kingdom
Estonia	New Caledonia	United States
Faroe Islands	New Zealand	Uruguay
Finland	Northern Mariana Islands	Virgin Islands (U.S.)
France	Norway
French Polynesia	Oman
Germany	Palau

Afghanistan	Korea, Dem. People’s Rep	Somalia
Burkina Faso	Liberia	South Sudan
Burundi	Madagascar	Sudan
Central African Republic	Malawi	Syrian Arab Republic
Chad	Mali	Togo
Congo, Dem. Rep	Mozambique	Uganda
Eritrea	Niger	Yemen, Rep.
Gambia, The	Rwanda
Guinea-Bissau	Sierra Leone

Albania	Equatorial Guinea	Moldova
Algeria	Fiji	Mongolia
Argentina	Gabon	Montenegro
Armenia	Georgia	North Macedonia
Azerbaijan	Grenada	Paraguay
Belarus	Guatemala	Peru
Belize	Indonesia	Samoa
Bosnia and Herzegovina	Iran, Islamic Rep.	Serbia
Botswana	Iraq	South Africa
Brazil	Jamaica	St. Lucia
Cabo Verde	Kazakhstan	St. Vincent and the Grenadines
China	Kosovo	Suriname
Colombia	Libya	Thailand
Cuba	Malaysia	Tonga
Dominica	Maldives	Türkiye
Dominican Republic	Marshall Islands	Turkmenistan
Ecuador	Mauritius	Tuvalu
El Salvador	Mexico	Ukraine